Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02206113 · ClinicalTrials.gov registry record · NA
Sit to Stand Intervention for Allina Health Employees
A NA study, sponsored by Allina Health System.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT02206113: Completed NA study, sponsored by Allina Health System.
NCT02206113 is a NA study that has completed, run by Allina Health System. The registered enrollment target is 39 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02206113, a NA study, has completed, sponsored by Allina Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
A 16 week pilot study for Allina call center employees to look at the psychological outcomes and biological markers after an intervention of using a standing work station. There were two groups: group 1 received, and was instructed to use, the standing work station for all 16 weeks, group 2 was a wait-list control group and received, and was instructed to use, the standing work station for the second 8 weeks. Psychological outcomes were measured at weeks 0, 4, 8, 12, and 16. Biological markers were measured at weeks 0, 8, and 16.
Primary Outcome
Change in quality of life will be measured through the administration of the PROMIS-29 questionnaire.
Interventions
- BEHAVIORAL Standing workstation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2013-05 |
| Est. Completion | 2013-11 |
| Phase | NA |
What the finished NCT02206113 record still lists
NCT02206113 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Standing workstation is the first listed.
NCT02206113 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02206113 about?
NCT02206113 is a clinical study titled "Sit to Stand Intervention for Allina Health Employees". A 16 week pilot study for Allina call center employees to look at the psychological outcomes and biological markers after an intervention of using a standing work station. There were two groups: group 1 received, and was instructed to use, the standing work station for all 16 weeks, group 2 was a wa...
What is the current status of trial NCT02206113?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2013-05. Estimated completion is 2013-11.
What interventions are being tested in trial NCT02206113?
The interventions under investigation include: Standing workstation (BEHAVIORAL).
Who is sponsoring clinical trial NCT02206113?
This trial is sponsored by Allina Health System, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02206113's enrollment target sits among peer trials
39 1536th of 2000 higher than 463 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia